human placental lactogen
lactogen
[lak´to-jen]hu·man pla·cen·tal lac·to·gen (HPL),
human placental lactogen
Chorionic somatomammotropin, hPL, human placental lactogen, human chorionic somatomammotropin A hormone produced during implantation of a fertilized egg, and secreted by the placenta; hPL regulates and coordinates fetal growth and metabolism and maternal metabolism Maternal effects Relative insulin resistance, ↑ circulating free fatty acids; hPL may optimize metabolism of nutrients by the fetus in 1st half of pregnancy; in 2nd half, there is little correlation between hPL levels and fetal well-being; hPL stimulates milk production and breast enlargement, and is somatotopic and luteotropic; urine and plasma HPL levels reflect placental size and are higher in diabetic mothers Ref range Rises during gestation, plateauing at 37 wks at 10 mg/mL; ♂ <0.5 mg/mL; non-pregnant ♀ <0.5 mg/mL; wks of gestation 5-27 <4.6 mg/mL; 28-31 wks, 2.4-6.1 mg/mL; 32-35 wks, 3.7-7.7 mg/mL; 36 wks to term, 5-8.6 mg/mL; hPL is ↓ in postmaturity syndrome, retarded growth, toxemia of pregnancy, threatened abortion; it is ↑ DM, Rh isoimmunization, hydatiform mole, choriocarcinoma Critical value <4 μg/mL after 30 wks gestationhu·man pla·cen·tal lac·to·gen
(hyū'măn plă-sen'tăl lak'tŏ-jen)Compare: bioregulator
Synonym(s): chorionic growth hormone-prolactin, human chorionic somatomammotropic hormone, placental growth hormone.